CG
BSX icon

Carmignac Gestion’s Boston Scientific BSX Stock Holding History

Carmignac Gestion’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-3,212,394
Closed -$115M – 139
2020
Q4 		$115M Buy
3,212,394
+16,319
+0.5% +$588K 1.21% 35
2020
Q3 		$122M Sell
3,196,075
-4,500
-0.1% -$173K 1.44% 25
2020
Q2 		$112M Buy
+3,200,575
New +$115M 1.55% 23

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.29B AUM 4.86% 1-Year Est. Return

Carmignac Gestion's BSX Position: Q1 2021 in Review

Carmignac Gestion sold out of Boston Scientific (BSX) in Q1 2021, closing a stake of 3,212,394 shares — an estimated $115M sold.

Carmignac Gestion first reported a position in BSX in Q2 2020 and held it in 3 quarters. The position peaked at $122M in Q3 2020. 832 funds tracked by Wall St. Rank hold BSX as of Q1 2021.

  • Carmignac Gestion reported no remaining Boston Scientific position as of Q1 2021 after selling out during the quarter.
  • Carmignac Gestion sold 3,212,394 Boston Scientific shares in Q1 2021, an estimated $115M.
  • Carmignac Gestion first reported a position in Boston Scientific in Q2 2020 and held it in 3 quarters.
  • Carmignac Gestion's Boston Scientific position peaked at $122M in Q3 2020.
  • 832 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2021.

Based on Carmignac Gestion's 13F filing for Q1 2021, filed 14 May 2021.